Dina Panagiotopoulos, MD

Clinical Professor
Department of Pediatrics
Medical Director, Provincial Mental Health Metabolic Program, BCCH
Medical Director, Type 2 Diabetes Program, BCCH
Education
Queen’s University, 1995, MD
University of Toronto, 1997, Pediatric Medicine Residency
University of British Columbia, 1998, Pediatric Medicine Residency
University of British Columbia, 2003, Pediatric Endocrinology Fellowship
Clinical Interests
Diabetes, Diabetes in First Nations
Research Interests
Diabetes Care in First Nations, Metabolic effects of antipsychotic agents, Type 1 Diabetes
Publications

1. Ronsley R, Rayter M, Smith DH, Davidson J, Panagiotopoulos C. Metabolic monitoring training program implementation in a community setting is associated with improved monitoring in second-generation antipsychotic-treated children. Can J Psychiatry 2012; 57(5):292-9.

2. Devlin AM, Ngai YF, Ronsley R, Panagiotopoulos C. Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics. Transl Psychiatry (2012) 2, e71, doi:10.1038/tp.2011.68; published online 24 January 2012.

3. Panagiotopoulos C, Ronsley R, Kuzeljevic B, Davidson J. Waist circumference is a sensitive screening tool for assessment of metabolic syndrome risk in children treated with second-generation antipsychotics. Can J Psychiatry 2012; 57(1):34-44.

4. Tomlin D, Naylor, PJ, McKay H, Zorzi A, Mitchell M, Panagiotopoulos C. The impact of Action Schools! BC on the health of Aboriginal children and youth living in rural and remote

Contact
4480 Oak Street, K4-213
Vancouver, BC V6H 3V4
Canada
phone: 604–875–2624
fax: 604–875–3231

Read More | No Comments